CELLULAR ADAPTATION IN MIGRAINEURS WITH CHRONIC DAILY HEADACHE

被引:26
作者
HERING, R
GARDINER, I
CATARCI, T
WHITMARSH, T
STEINER, T
DEBELLEROCHE, J
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT BIOCHEM,FULHAM PALACE RD,LONDON W6 8RF,ENGLAND
[2] CHARING CROSS HOSP,PRINCESS MARGARET MIGRAINE CLIN,LONDON W6 8RP,ENGLAND
关键词
D O I
10.1046/j.1468-2982.1993.1304261.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ergotamine and analgesic misuse are now recognized as causes of chronic daily headache and the condition responds well to drug withdrawal with reduced headache frequency. In this study, we have investigated whether medication misuse is associated with an alteration in membrane transduction which is sensitive to drug withdrawal. This was carried out by assay of the thrombin-stimulated generation of inositol phosphates in platelets from 12 migraine patients with chronic daily headache and analgesic misuse, 7 migraine patients with chronic daily headache and ergotamine misuse and 7 control subjects. After drug withdrawal, a significant decrease in headache frequency was seen at one month in both patient groups. Withdrawal of analgesics produced a significant decrease in thrombin-stimulated inositol phosphate production at one month; this was further decreased a month later with a reduction in B(max) of 60% and no significant change in K(D). A similar pattern was obtained in ergot misuse patients, with the K(D) value decreasing by 56% one month after drug withdrawal. These results provide evidence of an adaptation in transduction with misuse of analgesics and ergotamine which correlates with headache frequency.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 19 条
[1]   ERGOTAMINE ABUSE - RESULTS OF ERGOTAMINE DISCONTINUATION, WITH SPECIAL REFERENCE TO THE PLASMA-CONCENTRATIONS [J].
ALAHURULA, V ;
MYLLYLA, V ;
HOKKANEN, E .
CEPHALALGIA, 1982, 2 (04) :189-195
[2]   LONGTERM PROGNOSIS OF ANALGESIC WITHDRAWAL IN PATIENTS WITH DRUG-INDUCED HEADACHES [J].
BAUMGARTNER, C ;
WESSELY, P ;
BINGOL, C ;
MALY, J ;
HOLZNER, F .
HEADACHE, 1989, 29 (08) :510-514
[3]   ERYTHROCYTE CHOLINE CONCENTRATIONS AND CLUSTER HEADACHE [J].
DEBELLEROCHE, J ;
COOK, GE ;
DAS, I ;
JOSEPH, R ;
TRESIDDER, I ;
ROUSE, S ;
PETTY, R ;
ROSE, FC .
BRITISH MEDICAL JOURNAL, 1984, 288 (6413) :268-270
[4]  
DEBELLEROCHE J, 1988, HEADACHE, V28, P409
[5]   ABNORMAL MEMBRANE-COMPOSITION AND MEMBRANE DEPENDENT TRANSDUCTION MECHANISMS IN CLUSTER HEADACHE [J].
DEBELLEROCHE, J ;
KILFEATHER, S ;
DAS, I ;
ROSE, FC .
CEPHALALGIA, 1986, 6 (03) :147-153
[6]  
DEBELLEROCHE J, 1990, MIGRAINE SPECTRUM ID, P269
[7]  
DEBELLEROCHE J, 1991, NEW ADV HEADACHE RES, V2, P161
[8]   CLINICAL-FEATURES OF HEADACHES CAUSED BY ANALGESICS [J].
DIENER, HC .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (12) :472-474
[9]  
EDMEADS J, 1990, HEADACHE, V30, P615
[10]   THE PLATELET POLYPHOSPHOINOSITIDE SYSTEM IN SCHIZOPHRENIA - THE EFFECTS OF NEUROLEPTIC TREATMENT [J].
ESSALI, MA ;
DAS, I ;
DEBELLEROCHE, J ;
HIRSCH, SR .
BIOLOGICAL PSYCHIATRY, 1990, 28 (06) :475-487